Answers are grounded in this paper and cite their sources.
// Congcong Sun 1 , Lixian Chang 1 and Xiaofan Zhu 1 1 Center for Pediatric Blood Disease, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Tianjin, P.R. China Correspondence to: Xiaofan Zhu, email: // Keywords : ETV6/RUNX1, childhood acute lymphoblastic leukemia, mechanisms, initiation, relapse Received : November 21, 2016 Accepted : February 23, 2017 Published : March 18, 2017 Abstract ETV6/RUNX1 ( E/R ) is the most common fusion gene in childhood acute lymphoblastic leukemia (ALL). Multiple lines of evidence imply a “two-hit” model for the molecular pathogenesis of E/R -positive ALL, whereby E/R rearrangement is followed by a series of secondary mutations that trigger overt leukemia. The cellular framework in which E/R arises and the maintenance of a pre-leukemic condition by E/R are fundamental to the mechanism that underlies leukemogenesis. Accordingly, a variety of studies have focused on the relationship between the clones giving rise to the primary and recurrent E/R -positive ALL. We review here the most recent insights into the pathogenic mechanisms underlying E/R -positive ALL, as well as the molecular abnormalities prevailing at relapse.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: